Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes

Galina Smushkin, Airani Sathananthan, Chiara Dalla Man, Alan R. Zinsmeister, Michael Camilleri, Claudio Cobelli, Robert A. Rizza, Adrian Vella

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Context: There has beenmuchspeculation as to whether defects in glucagon-like peptide-1 (GLP-1) secretion play a role in the pathogenesis of type 2 diabetes and the progression from normal glucose tolerance to prediabetes and diabetes. Objective: Our objective was to determine whether fasting and postchallenge concentrations of active and total GLP-1 decrease as glucose tolerance and insulin secretion worsen across the spectrum of prediabetes. Design: This was a cross-sectional study. Setting: The study was performed in the clinical research unit of an academic medical center. Participants: Participants included 165 subjects with a fasting glucose below 7.0 mmol/liter and not taking medications known to affect gastrointestinal motility or glucose metabolism. Intervention: Intervention included a 2-h, 75-g oral glucose tolerance test with insulin, C-peptide, glucagon, and GLP-1 measurements at seven time points. Main Outcome Measure:Weevaluated the association of integrated, incremental active, and total GLP-1 concentrations with integrated, incremental glucose response to 75 g oral glucose. Results: After accounting for covariates, there was no evidence of a relationship of incremental glucose concentrations after oral glucose tolerance test with active and total GLP-1 (rs=-0.16 and P=0.14, and rs=0.00 and P>0.9, respectively). There also was no association of GLP-1 concentrations with insulin secretion and action. Conclusions: The lack of association of GLP-1 concentrations with glucose tolerance status and with insulin secretion and action in a cohort encompassing the full spectrum of prediabetes strongly argues against a significant contribution of defects in GLP-1 secretion to the pathogenesis of prediabetes.

Original languageEnglish (US)
Pages (from-to)589-598
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Prediabetic State
Glucagon-Like Peptide 1
Glucose
Defects
Insulin
Glucose Tolerance Test
Fasting
Medical problems
Gastrointestinal Motility
C-Peptide
Glucagon
Type 2 Diabetes Mellitus
Metabolism
Cross-Sectional Studies
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. / Smushkin, Galina; Sathananthan, Airani; Man, Chiara Dalla; Zinsmeister, Alan R.; Camilleri, Michael; Cobelli, Claudio; Rizza, Robert A.; Vella, Adrian.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 2, 02.2012, p. 589-598.

Research output: Contribution to journalArticle

Smushkin, Galina ; Sathananthan, Airani ; Man, Chiara Dalla ; Zinsmeister, Alan R. ; Camilleri, Michael ; Cobelli, Claudio ; Rizza, Robert A. ; Vella, Adrian. / Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 2. pp. 589-598.
@article{6b9572ae7b6549549460a404464845c4,
title = "Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes",
abstract = "Context: There has beenmuchspeculation as to whether defects in glucagon-like peptide-1 (GLP-1) secretion play a role in the pathogenesis of type 2 diabetes and the progression from normal glucose tolerance to prediabetes and diabetes. Objective: Our objective was to determine whether fasting and postchallenge concentrations of active and total GLP-1 decrease as glucose tolerance and insulin secretion worsen across the spectrum of prediabetes. Design: This was a cross-sectional study. Setting: The study was performed in the clinical research unit of an academic medical center. Participants: Participants included 165 subjects with a fasting glucose below 7.0 mmol/liter and not taking medications known to affect gastrointestinal motility or glucose metabolism. Intervention: Intervention included a 2-h, 75-g oral glucose tolerance test with insulin, C-peptide, glucagon, and GLP-1 measurements at seven time points. Main Outcome Measure:Weevaluated the association of integrated, incremental active, and total GLP-1 concentrations with integrated, incremental glucose response to 75 g oral glucose. Results: After accounting for covariates, there was no evidence of a relationship of incremental glucose concentrations after oral glucose tolerance test with active and total GLP-1 (rs=-0.16 and P=0.14, and rs=0.00 and P>0.9, respectively). There also was no association of GLP-1 concentrations with insulin secretion and action. Conclusions: The lack of association of GLP-1 concentrations with glucose tolerance status and with insulin secretion and action in a cohort encompassing the full spectrum of prediabetes strongly argues against a significant contribution of defects in GLP-1 secretion to the pathogenesis of prediabetes.",
author = "Galina Smushkin and Airani Sathananthan and Man, {Chiara Dalla} and Zinsmeister, {Alan R.} and Michael Camilleri and Claudio Cobelli and Rizza, {Robert A.} and Adrian Vella",
year = "2012",
month = "2",
doi = "10.1210/jc.2011-2561",
language = "English (US)",
volume = "97",
pages = "589--598",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes

AU - Smushkin, Galina

AU - Sathananthan, Airani

AU - Man, Chiara Dalla

AU - Zinsmeister, Alan R.

AU - Camilleri, Michael

AU - Cobelli, Claudio

AU - Rizza, Robert A.

AU - Vella, Adrian

PY - 2012/2

Y1 - 2012/2

N2 - Context: There has beenmuchspeculation as to whether defects in glucagon-like peptide-1 (GLP-1) secretion play a role in the pathogenesis of type 2 diabetes and the progression from normal glucose tolerance to prediabetes and diabetes. Objective: Our objective was to determine whether fasting and postchallenge concentrations of active and total GLP-1 decrease as glucose tolerance and insulin secretion worsen across the spectrum of prediabetes. Design: This was a cross-sectional study. Setting: The study was performed in the clinical research unit of an academic medical center. Participants: Participants included 165 subjects with a fasting glucose below 7.0 mmol/liter and not taking medications known to affect gastrointestinal motility or glucose metabolism. Intervention: Intervention included a 2-h, 75-g oral glucose tolerance test with insulin, C-peptide, glucagon, and GLP-1 measurements at seven time points. Main Outcome Measure:Weevaluated the association of integrated, incremental active, and total GLP-1 concentrations with integrated, incremental glucose response to 75 g oral glucose. Results: After accounting for covariates, there was no evidence of a relationship of incremental glucose concentrations after oral glucose tolerance test with active and total GLP-1 (rs=-0.16 and P=0.14, and rs=0.00 and P>0.9, respectively). There also was no association of GLP-1 concentrations with insulin secretion and action. Conclusions: The lack of association of GLP-1 concentrations with glucose tolerance status and with insulin secretion and action in a cohort encompassing the full spectrum of prediabetes strongly argues against a significant contribution of defects in GLP-1 secretion to the pathogenesis of prediabetes.

AB - Context: There has beenmuchspeculation as to whether defects in glucagon-like peptide-1 (GLP-1) secretion play a role in the pathogenesis of type 2 diabetes and the progression from normal glucose tolerance to prediabetes and diabetes. Objective: Our objective was to determine whether fasting and postchallenge concentrations of active and total GLP-1 decrease as glucose tolerance and insulin secretion worsen across the spectrum of prediabetes. Design: This was a cross-sectional study. Setting: The study was performed in the clinical research unit of an academic medical center. Participants: Participants included 165 subjects with a fasting glucose below 7.0 mmol/liter and not taking medications known to affect gastrointestinal motility or glucose metabolism. Intervention: Intervention included a 2-h, 75-g oral glucose tolerance test with insulin, C-peptide, glucagon, and GLP-1 measurements at seven time points. Main Outcome Measure:Weevaluated the association of integrated, incremental active, and total GLP-1 concentrations with integrated, incremental glucose response to 75 g oral glucose. Results: After accounting for covariates, there was no evidence of a relationship of incremental glucose concentrations after oral glucose tolerance test with active and total GLP-1 (rs=-0.16 and P=0.14, and rs=0.00 and P>0.9, respectively). There also was no association of GLP-1 concentrations with insulin secretion and action. Conclusions: The lack of association of GLP-1 concentrations with glucose tolerance status and with insulin secretion and action in a cohort encompassing the full spectrum of prediabetes strongly argues against a significant contribution of defects in GLP-1 secretion to the pathogenesis of prediabetes.

UR - http://www.scopus.com/inward/record.url?scp=84856784864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856784864&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-2561

DO - 10.1210/jc.2011-2561

M3 - Article

C2 - 22090278

AN - SCOPUS:84856784864

VL - 97

SP - 589

EP - 598

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -